Covalent inhibition has seen a resurgence in the last
several years.
Although long-plagued by concerns of off-target effects due to nonspecific
reactions leading to covalent adducts, there has been success in developing
covalent inhibitors, especially within the field of anticancer therapy.
Covalent inhibitors can have an advantage over noncovalent inhibitors
since the formation of a covalent adduct may serve as an additional
mode of selectivity due to the intrinsic reactivity of the target
protein that is absent in many other proteins. Unfortunately, many
covalent inhibitors form irreversible adducts with off-target proteins,
which can lead to considerable side-effects. By designing the inhibitor
to form reversible covalent adducts, one can leverage competing on/off
kinetics in complex formation by taking advantage of the law of mass
action. Although covalent adducts do form with off-target proteins,
the reversible nature of inhibition prevents accumulation of the off-target
adduct, thus limiting side-effects. In this perspective, we outline
important characteristics of reversible covalent inhibitors, including
examples and a guide for inhibitor development.